SONM DNA X, Inc.
Technology$4.11+0.00%OpenMarket Cap: $4.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-68.28
P/S
-0.28
EV/EBITDA
-0.60
DCF Value
$-0.58
FCF Yield
-635.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.7%
Operating Margin
57.8%
Net Margin
88.4%
ROE
668.2%
ROA
-305.4%
ROIC
-101.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-3.6M | $6.3M | $— | — |
| Q4 null | $-44.1M | 34.7% | $4.7M | $-8.9M | $— | — |
| FY null | $0.00 | -Infinity% | $-5.4M | $-20.7M | $— | — |
| Q3 null | $16.2M | 11.2% | $-4.0M | $-4.8M | $— | — |
| Q2 null | $11.2M | 7.6% | $-6.7M | $-7.5M | $— | — |
| Q1 null | $16.7M | 50.0% | $645.0K | $458.0K | $— | — |
| Q4 null | $15.0M | -1.2% | $-22.1M | $-21.6M | $— | — |
| FY null | $58.3M | 17.0% | $-33.6M | $-33.6M | $— | — |
| Q3 null | $15.0M | 28.2% | $-2.4M | $-2.5M | $— | — |
| Q2 null | $11.5M | 25.8% | $-6.5M | $-6.6M | $— | — |
| Q1 null | $16.8M | 17.3% | $-2.7M | $-2.9M | $— | — |
| Q4 2023 | $13.4M | 38.1% | $-1.3M | $-1.4M | $-0.31 | — |